AI Science Tracker
EN

National Institute of Blood Diseases and Bone Marrow Transplantation

1 discovery from 2022

Discoveries

Artificial Intelligence with CBC based Morphometric Parameters aimed toward effective diagnostic practices for Dysplasia associated Hematological Malignancies

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning classification of CBC morphometric and cell-population features distinguished dysplasia-associated hematologic malignancy groups in a retrospective clinical sample. The result is limited to the study’s patient groups and does not establish prospective diagnostic performance.

Technology: Machine-learning classifiers assess dysplasia-associated hematologic malignancy from CBC morphometric features.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning classifiers assess dysplasia-associated hematologic malignancy from CBC morphometric features.
Test and result
CBC morphometric and cell-population measurements were evaluated with machine-learning classifiers for dysplasia-associated hematologic malignancy groups.
Limitation / still unknown
The evidence is retrospective and limited to the reported patient groups; prospective workflow validation was not shown.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://assets-eu.researchsquare.com/files/rs-1349008/v1/da889f2c-9039-4610-b8c2-7cd4874ad4dd.pdf · https://api.crossref.org/works/10.21203/rs.3.rs-1349008/v1

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.